Analysts at StockNews.com initiated coverage on shares of NuVasive (NASDAQ:NUVA – Free Report) in a research report issued on Saturday. The firm set a “hold” rating on the medical device company’s stock. A number of other brokerages have also recently commented on NUVA. TheStreet upgraded NuVasive from a “d+” rating to a “c-” rating in […]